发明授权
- 专利标题： PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS
- 专利标题（中）： 吡唑并嘧啶作为抑制剂细胞周期蛋白依赖性激酶
-
申请号： EP03749347.5申请日： 2003-09-03
-
公开(公告)号： EP1534710B1公开(公告)日： 2007-10-24
- 发明人: GUZI, Timothy, J. , PARUCH, Kamil , DWYER, Michael, P. , DOLL, Ronald, J. , GIRIJAVALLABHAN, Viyyoor, Moopil , DILLARD, Lawrence, W. , TRAN, Vinh, D. , HE, Zhen Min , JAMES, Ray, Anthony , PARK, Haengsoon
- 申请人： Schering Corporation , PHARMACOPEIA, INC.
- 申请人地址： 2000 Galloping Hill Road Kenilworth, NJ 07033-0530 US
- 专利权人： Schering Corporation,PHARMACOPEIA, INC.
- 当前专利权人： Schering Corporation,PHARMACOPEIA, INC.
- 当前专利权人地址： 2000 Galloping Hill Road Kenilworth, NJ 07033-0530 US
- 代理机构： UEXKÜLL & STOLBERG
- 优先权： US407999P 20020904
- 国际公布： WO2004022560 20040318
- 主分类号： C07D487/04
- IPC分类号： C07D487/04 ; A61K31/519 ; A61P25/00 ; A61P35/00
摘要：
In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.
公开/授权文献
- EP1534710A1 PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS 公开/授权日：2005-06-01
信息查询
